NeuroPace (NPCE)
NASDAQ:NPCE
US Market

NeuroPace (NPCE) Stock Investors

105 Followers
Based on 748,394 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NPCE
On average, investors allocate 0.00% of their portfolios to NPCE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 748,394 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NPCE

1.7%
Last 7
Days
3.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NPCE, out of 748,394 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NPCE Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,208 investors who made their portfolios public
The table shows changes in NPCE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NPCE Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
VICI Properties
4.28%
-0.26%
+1.78%
31.51B
Real Estate
DraftKings
5.82%
-1.05%
-2.25%
31.47B
Consumer Cyclical
UiPath
3.33%
-1.01%
-2.43%
6.83B
Technology
Zscaler
3.81%
-1.07%
+1.02%
27.48B
Technology
Microstrategy
7.03%
+0.34%
+7.13%
29.67B
Technology
Vanguard Total Stock Market ETF
8.89%
-0.84%
+1.84%
420.61B
General
Trade Desk
4.72%
-1.00%
+0.17%
43.69B
Technology
GE Aerospace
5.29%
+1.40%
+2.66%
175.98B
Industrials
AMC Entertainment
5.74%
-1.13%
-3.96%
1.39B
Communication Services
Coherus Biosciences
2.57%
-1.70%
-5.58%
173.24M
Healthcare
Based on the activity of 748,394 active portfolios
Open your Smart Portfolio

NPCE Investor Analysis

NPCE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
0.0%
of NPCE holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
NPCE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
62.5%
of NPCE holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
NPCE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
37.5%
of NPCE holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of NPCE stock investors
See who invests in NPCE according to age group and performance.

FAQ

How many retail Investors hold NPCE?
<0.1% of TipRanks' retail investors hold NPCE in their portfolios.
    What is NPCE Investor Sentiment?
    NPCE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of NPCE in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of NPCE in the last 7 days.
        What percentage of retail investors changed their holding of NPCE in the last 30 days?
        ▼ 3.1% of TipRanks' retail investors changed their holding of NPCE in the last 30 days.
          What is the average age of retail investors who hold NPCE?
          The average age of NPCE Holders is between 35–55.
            What other stocks have NPCE investors also bought?
            NPCE Investors also bought VICI, DKNG, PATH, ZS, MSTR, VTI, TTD, GE, AMC, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BAXBaxter International
              BCRXBioCryst
              CRLCharles River Labs
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis